
Current myeloproliferative neoplasm scoring systems for clinical practice
In this medfyle
This article provides an overview of the incidence of events associated with MPN progression and offers a comprehensive, comparative review of the currently available risk scoring systems. Finally, it proposes an algorithm for applying these scales in clinical practice.
About this Medfyle
©2025 Medfyle. All rights reserved.
This Medfyle is provided as a service to healthcare professionals. It has been created from content originally published in Blood, American Society of Hematology's official journal.
Original article: Pasquer H, Kiladjian JJ, Benajiba L. Current myeloproliferative neoplasm scoring systems for clinical practice. Blood. 2025 Jan 16;145(3):257-276.